Vilin Bio Med (NSE:VILINBIO) Scaled Net Operating Assets : N/A (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vilin Bio Med's operating assets for the quarter that ended in Sep. 2023 was ₹244.12 Mil. Vilin Bio Med's operating liabilities for the quarter that ended in Sep. 2023 was ₹19.74 Mil. Vilin Bio Med's Total Assets for the quarter that ended in Sep. 2022 was ₹0.00 Mil. Therefore, Vilin Bio Med's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2023 was N/A.

Vilin Bio Med Scaled Net Operating Assets Historical Data

The historical data trend for Vilin Bio Med's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Scaled Net Operating Assets Chart

Vilin Bio Med Annual Data

Trend

Mar20

Mar21

Mar22

Scaled Net Operating Assets

0.84

0.92

0.91

Vilin Bio Med Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Sep23
Scaled Net Operating Assets	0.84	0.92	0.91	-	-

Competitive Comparison of Vilin Bio Med's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vilin Bio Med's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Vilin Bio Med's Scaled Net Operating Assets falls into.

Vilin Bio Med Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vilin Bio Med's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2022 )
=	(Operating Assets (A: Mar. 2022 )	-	Operating Liabilities (A: Mar. 2022 ))	/	Total Assets (A: Mar. 2021 )
=	(135.193	-	8.625)	/	138.914
=	0.91

where

	Operating Assets		(A: Mar. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	135.583	-	0.39
=	135.193

	Operating Liabilities		(A: Mar. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	61.621	-	7.34	-	45.656
=	8.625

Vilin Bio Med's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2023 )
=	(Operating Assets (Q: Sep. 2023 )	-	Operating Liabilities (Q: Sep. 2023 ))	/	Total Assets (Q: Sep. 2022 )
=	(244.12	-	19.735)	/	0
=	N/A

where

	Operating Assets		(Q: Sep. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	309.444	-	65.324
=	244.12

	Operating Liabilities		(Q: Sep. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	74.977	-	2.525	-	52.717
=	19.735

Vilin Bio Med Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

N/A

Address

Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009

Website

http://www.vilinbiomed.co.in

Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines